67 Spam-Free Article(s) Found
Sort:
Like
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Lilly, Amgen Ink Manufacturing Deal for Coronavirus Antibodies http://www.zacks.com/stock/news/1060524/lilly-amgen-ink-manufacturing-deal-for-coronavirus-antibodies?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-1060524 Sep 18, 2020 - Eli Lilly (LLY) is developing several potential neutralizing antibodies to treat COVID-19.
4 Reasons to Bet on Small-Cap ETFs Now http://www.zacks.com/stock/news/1063335/4-reasons-to-bet-on-small-cap-etfs-now?cid=CS-ZC-FT-etf_news_and_commentary-1063335 Sep 25, 2020 - Small-cap stocks were hurt badly during the peak of the coronavirus-led lockdowns. Now, the gradual uptick of reopening trade has started to favor the small-cap spectrum.
Bristol Myers (BMY) Clinches FDA Nod for MS Drug Zeposia http://www.zacks.com/stock/news/838749/bristol-myers-bmy-clinches-fda-nod-for-ms-drug-zeposia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-838749 Mar 27, 2020 - The FDA approves Bristol Myers' (BMY) Zeposia for the treatment of adults with relapsing forms of multiple sclerosis.
AVEO Stops AML Study on Ficlatuzumab Amid Coronavirus Pandemic http://www.zacks.com/stock/news/845462/aveo-stops-aml-study-on-ficlatuzumab-amid-coronavirus-pandemic?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-845462 Mar 30, 2020 - AVEO ceases the phase II CyFi-2 study on ficlatuzumab plus high-dose cytarabine for treating patients with relapsed/refractory acute myeloid leukemia to combat the COVID-19 outbreak.
Lilly's Taltz Gets FDA Nod for Plaque Psoriasis in Children http://www.zacks.com/stock/news/847430/lillys-taltz-gets-fda-nod-for-plaque-psoriasis-in-children?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-847430 Mar 31, 2020 - The FDA approves Eli Lilly's (LLY) sBLA for Taltz injection to treat pediatric patients with moderate to severe plaque psoriasis. Stock up.
Bristol Myers, bluebird Submit BLA for Myeloma Drug to FDA http://www.zacks.com/stock/news/849395/bristol-myers-bluebird-submit-bla-for-myeloma-drug-to-fda?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-849395 Apr 01, 2020 - Bristol Myers (BMY) and bluebird file a biologics license application to the FDA seeking approval of idecabtagene vicleucel for heavily pre-treated patients with multiple myeloma. Stock gains.
LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day http://www.zacks.com/stock/news/851380/lly-oxm-amag-mist-and-cpix-as-zacks-bull-and-bear-of-the-day?cid=CS-ZC-FT-press_releases-851380 Apr 02, 2020 - LLY, OXM, AMAG, MIST and CPIX as Zacks Bull and Bear of the Day
Top Analyst Reports for Eli Lilly, Charter Communications & Eaton http://www.zacks.com/research-daily/851105/top-analyst-reports-for-eli-lilly-charter-communications-eaton?cid=CS-ZC-FT-research_daily-851105 Apr 02, 2020 - Top Analyst Reports for Eli Lilly, Charter Communications & Eaton
Here's Why You Should Buy Lilly Stock Amid Coronavirus Crisis http://www.zacks.com/stock/news/851267/heres-why-you-should-buy-lilly-stock-amid-coronavirus-crisis?cid=CS-ZC-FT-analyst_blog|rank_focused-851267 Apr 02, 2020 - Lilly (LLY) enjoys strong fundamentals, which can help it withstand the short-term impact of the pandemic.
Why Eli Lilly (LLY) is a Top Dividend Stock for Your Portfolio http://www.zacks.com/stock/news/852982/why-eli-lilly-lly-is-a-top-dividend-stock-for-your-portfolio?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_5-852982 Apr 03, 2020 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Eli Lilly (LLY) have what it takes? Let's find out.

Pages: 1234567

<<<Page 4>